The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Prevalence of Symptomatic Androgen Deficiency in Men
Abstract
Context: Despite recognition that androgen deficiency in men should be defined according to biochemical and clinical criteria, most prevalence estimates are based on low testosterone levels alone. Objective: The objective of this study was to examine the association between symptoms of androgen deficiency and low total and calculated free testosterone levels and estimate the prevalence of symptomatic androgen deficiency in men. Design: This study was a population-based, observational survey. Participants: A total of 1475 Black, Hispanic, and white men, between the ages of 30–79 yr, with complete data on testosterone, SHBG, and symptoms of androgen deficiency, and who are not taking medications that impact sex steroid levels were randomly selected from the Boston Area Community Health Survey. Outcome: Outcomes were measured as symptomatic androgen deficiency, defined as low total (<300 ng/dl) and free (<5 ng/dl) testosterone plus presence of low libido, erectile dysfunction, osteoporosis or fracture, or two or more of following symptoms: sleep disturbance, depressed mood, lethargy, or diminished physical performance. Results: Mean age of the sample was 47.3 ± 12.5 yr. Approximately 24% of subjects had total testosterone less than 300 ng/dl, and 11% of subjects had free testosterone less than 5 ng/dl. Prevalence of symptoms were as follows: low libido (12%), erectile dysfunction (16%), osteoporosis/fracture (1%), and two or more of the nonspecific symptoms (20%). Low testosterone levels were associated with symptoms, but many men with low testosterone levels were asymptomatic (e.g. in men 50+ yr, 47.6%). Crude prevalence of symptomatic androgen deficiency was 5.6% (95% confidence interval: 3.6%, 8.6%), and was not significantly related to race and ethnic group. Prevalence was low in men less than 70 yr (3.1–7.0%) and increased markedly with age to 18.4% among 70 yr olds. Projection of these estimates to the year 2025 suggests that there will be as many as 6.5 million American men ages 30–79 yr with symptomatic androgen deficiency, an increase of 38% from 2000 population estimates. Conclusions: Prevalence of symptomatic androgen deficiency in men 30 and 79 yr of age is 5.6% and increases substantially with age. The aging of the U.S. male population will cause a large increase in the burden of symptomatic androgen deficiency. Future work should address the clinical significance of low testosterone levels in asymptomatic men.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The prevalence of symptomatic hypogonadism remains poorly defined, with estimates ranging from 2.1–17% in population-based surveys of men aged 30–87 years depending upon criterion utilized.”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [2]
In the citing paper
“However, many of these studies are hindered by heterogeneity in the definition for low fT (50–65 pg/ml [173.4–225.4 pmol/L]), with increases in the threshold for low fT resulting in higher sensitivity and reduced specificity when compared to TT.”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [2]
In the citing paper
“Other studies have also demonstrated increased associations between fT and other comorbid conditions, including depression and hypogonadal symptoms.”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [2]
In the citing paper
“Free T is also better indicator in young males as compared to elderly men, suggesting that the age-associated increase in SHBG may further reduce the specificity of fT.”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [2]
In the citing paper
“The authors noted that increasing the lower fT threshold (50–60, or 60–70pg/ml [173.4–208 and 208–242.7 pmol/L]) resulted in reduced specificity for symptoms such as low libido (28.1%, 23.9%, and 19.8% for 50, 60, and 70pg/ml [242.7 pmol/L], respectively).”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [2]
In the citing paper
“The community prevalence estimates of potentially functional hypogonadism in middle-aged and older men (also referred to as late-onset, age-related, or adult-onset hypogonadism) vary from 2.1% to 12.3% (8–10)”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [9]
In the citing paper
“In other observational studies of middle-aged and older men, symptoms and low testosterone also seldomly occurred together (Supplemental Fig. 1) (8–10).”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [9]
Citations
Cites
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392
Brown, R. A., Hastie, T. J., & Tibshirani, R. J. (1991) · Biometrics · doi:10.2307/2532174 · Cited by 8,263
Koyak, R. A., Hastie, T. J., & Tibshirani, R. J. (1991) · Journal of the American Statistical Association · doi:10.2307/2290538 · Cited by 7,717
Rosen, R. C., Riley, A., Wagner, G., Osterloh, I. H., Kirkpatrick, J., & Mishra, A. (1997) · Urology · doi:10.1016/s0090-4295(97)00238-0 · Cited by 5,849
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861
Self-citationSödergard, R., Bäckström, T., Shanbhag, V., & Carstensen, H. (1982) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(82)90038-3 · Cited by 1,080
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2847 · Cited by 965
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 722
Sexual desire in older men and its association with serum testosterone and other factors
Peña, G. M., Rodríguez, Y. L., Llanes, L. L., Alzugaray, M. G., Carballo, G. O., Seijas, E. Á., & Torres, E. R. (2016) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 3
Perry‐Keene, D. A. (2014) · Australian Prescriber · doi:10.18773/austprescr.2014.076 · Cited by 3
Hypogonadotropic and Hypergonadotropic Hypogonadism
Surampudi, V., & Swerdloff, R. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-46086-4_6 · Cited by 3
DeFina, L. F., Radford, N. B., Leonard, D. S., Wilson, R. K., Cooper, T. C., Clark, S. M., Vega, G. L., Barlow, C. E., Willis, B. L., Gibbons, L. W., et al. (2019) · Journal of Investigative Medicine · doi:10.1136/jim-2019-001083 · Cited by 3
Long‐term testosterone undecanoate replacement therapy: Impact of ethnicity
Kempegowda, P., Quinn, L. M., Chandan, J. S., Shepherd, L. M., Kauser, S., Rahim, A., & Bates, A. T. (2020) · Clinical Endocrinology · doi:10.1111/cen.14157 · Cited by 3
Allan, C. A., & McLachlan, R. I. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00139-6 · Cited by 4
Взаємозв’язок гіпотиреозу та андрогенного дефіциту у чоловіків в різні періоди зрілого віку
Krytskyi, T. I., & Pasyechko, N. V. (2018) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.14.1.2018.127089 · Cited by 3
Epidemiology of male sexual dysfunction
Tal, R. (2016) · Wiley eBooks · doi:10.1002/9781118746509.ch1 · Cited by 3
Ho, C., Yu, H., Wang, C., Jaw, F., Hsieh, J., Liao, W.-C., Pu, Y., & Liu, S. (2013) · PLoS ONE · doi:10.1371/annotation/c226aa64-8d3b-4c29-971b-84f87b618291 · Cited by 4
Seasonal Variation in Serum Testosterone Levels: Evidence from 2 Large Institutional Databases
Miller, D., Gurayah, A. A., Weber, A., Schuppe, K. C., Zarli, M., Dullea, A. D., Hwang, K., & Ramasamy, R. (2023) · Urology Research and Practice · doi:10.5152/tud.2023.23077 · Cited by 2
Corsini, C., Pozzi, E., Belladelli, F., Bertini, A., Negri, F., Raffo, M., Boeri, L., Ventimiglia, E., Candela, L., d’Arma, A., et al. (2025) · International Journal of Impotence Research · doi:10.1038/s41443-025-01029-2 · Cited by 2
Lee, J. Y., Choi, H., Choi, K., Jo, M., Yoo, J., & Lee, Y. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106783 · Cited by 2
Chen, Y., Zhuang, Q., Xia, W., Shao, N., Zhang, B., & Feng, X. (2025) · Scientific Reports · doi:10.1038/s41598-025-04521-3 · Cited by 2
Liu, V. N., Huang, D. R., Alaa, A., Hayhoe, B. W. J., & El-Osta, A. A. R. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-094145 · Cited by 2
Huang, R., Zhu, W.-J., Li, J., & Gu, Y. (2014) · Pathology - Research and Practice · doi:10.1016/j.prp.2014.05.003 · Cited by 2
Low Testosterone in Men Should Be a Sign Rather Than a Number to Increase
Aktürk, H. K., & Nippoldt, T. B. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.5761 · Cited by 2
Campos‐Juanatey, F., Diago, C. A. A., Malo, R. V., Calvo, J. A., Gómez, M. Á. C., & Martín, J. A. P. (2019) · Revista Internacional de Andrología · doi:10.1016/j.androl.2019.04.006 · Cited by 2
Simoni, M., & Nieschlag, E. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-61901-8_7 · Cited by 2
Basulto-Natividad, A., Coria‐Ávila, G. A., Aranda-Abreu, G. E., Manzo, J. G., Toledo-Cárdenas, R., Hernández‐Aguilar, M. E., & Herrera‐Covarrubias, D. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114338 · Cited by 2
Cell Biology and Regulation of Adult and Aging Leydig Cell Steroidogenesis
Papadopoulos, V., Garza, S., & Zirkin, B. R. (2025) · Springer eBooks · doi:10.1007/978-3-031-96376-6_4 · Cited by 2
Anabolic/Androgenic Steroids in Skeletal Muscle and Cardiovascular Diseases
Basualto-Alarcn, C., Maass, R., Jaimovich, E., & Estr, M. (2013) · InTech eBooks · doi:10.5772/53080 · Cited by 2
Andrology: Puberty-Fertility-Andropause
Guo, D. P., & Eisenberg, M. L. (2015) · Springer eBooks · doi:10.1007/978-1-4939-3237-5_9 · Cited by 2
Greenberg, D. R., Hudnall, M. T., Goyette, B. N., Lai, J. D., Hayon, S., Bennett, N., Brannigan, R. E., & Halpern, J. A. (2023) · Urology · doi:10.1016/j.urology.2023.07.011 · Cited by 2
Davis, R., Hershenhouse, J. S., Maas, M., Loh-Doyle, J. C., & Asanad, K. (2025) · The Journal of Sexual Medicine · doi:10.1093/jsxmed/qdaf043 · Cited by 2
Rastrelli, G., Maggi, M., & Corona, G. (2025) · Springer eBooks · doi:10.1007/978-3-031-55405-6_56 · Cited by 2
Robert Benjamin Greenblatt and His Many Pursuits: An Unlikely Founder of the Testosterone Pellet
Reinstatler, L. S., Klaassen, Z. W. A., McCraw, C. O., Chen, R., Terris, M. K., Neal, D. E., Lewis, R. W., & Smith, A. M. (2015) · Urology · doi:10.1016/j.urology.2014.10.012 · Cited by 2
Identifying late-onset hypogonadism in older men
Jones, T. H. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2010.162 · Cited by 2
Androgens and cardiac diseases
Bianchi, V. E., & Mezzani, A. (2013) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2013.5232 · Cited by 2
Morgado, A., Moura, M. L., Dinis, P., & Silva, C. (2019) · International Journal of Impotence Research · doi:10.1038/s41443-019-0169-0 · Cited by 2
Wangikar, P. B., Gupta, P. K., Choudhari, B., & Sharma, R. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820728-4.00009-5 · Cited by 2
The Roles of Aromatase Inhibitors in Treating Hypogonadism and Male Infertility
Huang, W. J. (2022) · Urological Science · doi:10.4103/uros.uros_28_22 · Cited by 2
Prevalence of men's health history in male breast cancer patients
Scagliotti, M. F., Boietti, B. R., & Knoblovits, P. (2022) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2022.02.024 · Cited by 2
The Aging Male and Late-Onset Hypogonadism
Rolf, C., Zitzmann, M., & Nieschlag, E. (2010) · Springer eBooks · doi:10.1007/978-3-540-78355-8_14 · Cited by 2
Topical Testosterone Gel for the Treatment of Male Hypogonadism
Udeoji, D. U., Phan, A., Katsiyiannis, P., Willix, R., & Schwarz, E. R. (2012) · Clinical Medicine Insights Therapeutics · doi:10.4137/cmt.s7348 · Cited by 2
Testosterone replacement and cardiovascular disease risk
Gonzalez, J. R., & Goldstein, I. (2015) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000051 · Cited by 2
Morgentaler, A., Zitzmann, M., Traish, A. M., Fox, A. W., Jones, T. H., Maggi, M., Arver, S., Aversa, A., Chan, J. C. N., Dobs, A. S., et al. (2016) · Obesity and metabolism · doi:10.14341/omet2016315-31 · Cited by 2
Leydig Cell Development and Aging in the Brown Norway Rat
Zirkin, B. R., Chen, H., & Papadopoulos, V. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00062-2 · Cited by 2
Pituitary Evaluation in Patients with Low Prostate-Specific Antigen
Drincic, A., Nguyen, A.-T., Singh, S., Zena, M., Walters, R. W., Friedman, K., & Anderson, R. J. (2018) · Endocrine Practice · doi:10.4158/ep-2018-0204 · Cited by 2
Shores, M. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-54482-9_12 · Cited by 2
Ammini, A. C., Somasundaram, S., & Goswami, R. (2017) · Springer eBooks · doi:10.1007/978-981-10-3695-8_16 · Cited by 2
Role of testosterone in older men: recent advances and future directions
Yeap, B. B. (2008) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.3.4.415 · Cited by 2
Sobel, S. I., Brooks, H. E., Schwartz, R. S., & Kohrt, W. M. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-4975-1.00065-6 · Cited by 2
Erectile dysfunction and infertility
Soni, V., Pastuszak, A. W., & Khera, M. (2016) · Wiley eBooks · doi:10.1002/9781118746509.ch18 · Cited by 2
Meston, C. M., & Stanton, A. M. (2017) · Psychopathology · doi:10.1002/9781394258949.ch13 · Cited by 2
Transdermal Testosterone Gel Treatment of Hypogonadal Men
Han, T. S., & Bouloux, P. M. (2008) · Aging Health · doi:10.2217/1745509x.4.5.517 · Cited by 1
Чоловічий гіпогонадизм (частина 2)
Luchytskyy, Y. V., Luchytskyi, V. Y., & Tronko, M. D. (2017) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.13.5.2017.110030 · Cited by 1
Factors affecting adherence to testosterone replacement therapy
Gül, A., Yürük, E., Çulha, M. G., Serefoglu, E., & Muslumanoglu, A. (2018) · Translational Surgery · doi:10.4103/ts.ts_5_18 · Cited by 1
Parasher, A., Ranjan, K., & Munjal, V. (2021) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20212238 · Cited by 1
Schmidt, M. K., Rohayem, J., Zitzmann, M., Gelhorn, H. L., & Schneider, G. (2022) · Andrologia · doi:10.1111/and.14370 · Cited by 1
Is Testosterone the “Fountain of Youth” for Aging Men?
Giagulli, V. A., Lisco, G., Mariano, F., Tullio, A. D., & Triggiani, V. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530322666220516160435 · Cited by 1
Abichandani, V. K., & Kalhan, A. (2023) · Chronicle of Diabetes Research and Practice · doi:10.4103/cdrp.cdrp_cdrp_20_22 · Cited by 1
Magnussen, L. V., Jørgensen, L. H., Glintborg, D., & Andersen, M. (2023) · Biomedicines · doi:10.3390/biomedicines11123184 · Cited by 1
López, G. P., Cebrián, S. B., Fernández, L. G., & Albarrán, O. G. (2024) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2024.09.003 · Cited by 2
Baas, D. J. H., van Drumpt, J., Kiemeney, L. A. L. M., Beck, J. J. H., Østergren, P. B., Sedelaar, J. P. M., Hoekstra, R. J., Spruyt, A. B., van Melick, H., Bruins, M. H., et al. (2025) · European Urology Oncology · doi:10.1016/j.euo.2025.05.024 · Cited by 1
Diagnosis and management of male hypogonadism in Germany
Zitzmann, M., Ortius‐Lechner, D., Thierfelder, N., Schindler, C. J. A., & Häckl, D. (2025) · The Aging Male · doi:10.1080/13685538.2025.2602243 · Cited by 1
Kwon, H. O., Lee, S. H., In, G., So, S. H., Shim, S. L., Jang, K. H., & Kim, J. H. (2026) · American Journal of Men s Health · doi:10.1177/15579883261423878 · Cited by 1
Testosterone kinetics on hypogonadal men under clomiphene
Silva, É. D., da Silva, M. M., Moretti, T. B. C., Andrade, D. L., Avilez, N. D., & Reis, L. O. (2022) · International Urology and Nephrology · doi:10.1007/s11255-022-03230-4 · Cited by 1
Ishikawa, K., Tsujimura, A., Kanda, T., Narita, S., Anno, Y., Wakita, H., Taniguchi, A., Uesaka, Y., Nozaki, T., Shirai, M., et al. (2025) · International Journal of Urology · doi:10.1111/iju.70128 · Cited by 1
Abnormalities of Endocrine Function Tests in COVID-19-Recovered Individuals
Nonglait, P. L., Madhu, S. V., Raizada, N., Aggarwal, A., Ahmed, R. S., & Aslam, M. (2025) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_32_25 · Cited by 1
van de Stadt, S. I. W., Wessel, A. M. A., Langeveld, M., Engelen, M., & Sjouke, B. (2025) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.70121 · Cited by 1
Seneszenz und Altershypogonadismus
Rolf, C., Zitzmann, M., & Nieschlag, E. (2009) · Springer eBooks · doi:10.1007/978-3-540-92963-5_14 · Cited by 1
Male partial hypogonadotrophic hypogonadism with gynaecomastia and metabolic syndrome.
Ahsan, T., & Banu, Z. (2012) · PubMed · Cited by 1
Saad, F. (2016) · Adipositas - Ursachen Folgeerkrankungen Therapie · doi:10.1055/s-0037-1617716 · Cited by 1
Störung mit verminderter sexueller Appetenz beim Mann
Neuhof, C., & Hartmann, U. H. (2017) · Springer eBooks · doi:10.1007/978-3-662-54415-0_12 · Cited by 1
Edwards, R. Z. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35868-2.00064-5 · Cited by 1
Kirby, M. G., Kalhan, A., & Hackett, G. I. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1773259 · Cited by 1
Singh, R. P., Tomar, V., & Yadav, S. S. (2021) · Journal of Clinical Urology · doi:10.1177/20514158211040712 · Cited by 1
Rajandram, R., Koong, J. K., Quek, K. F., Lee, E. G., Razack, A. H. A., & Kuppusamy, S. (2022) · Clinical Endocrinology · doi:10.1111/cen.14682 · Cited by 1
[Testosterone levels in patients with varicocele and azoospermia].
Peng, J., Fang, D., Zhang, Z. C., Gao, B., Yuan, Y., Tang, Y., Song, W., & Cui, W. (2022) · PubMed Central · doi:10.19723/j.issn.1671-167x.2022.02.016 · Cited by 1
Hypogonadotropic and Hypergonadotropic Hypogonadism
Rajbhandari, P., Han, J. S., Wang, C., & Swerdloff, R. S. (2023) · Springer eBooks · doi:10.1007/978-3-031-31501-5_7 · Cited by 1
Bamaniya, B. B., Mavuduru, R. M., Bora, G. S., Sharma, A. J., Singh, S., & Rastogi, A. (2023) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2023.v16i8.48075 · Cited by 1
Banov, D., Biundo, B., Ip, K., Shan, A., Banov, F., Song, G., & de Carvalho, M. H. C. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16050621 · Cited by 1
Muthina, R. A., Koppara, N. K., Kiranmayi, V., Vaikkakara, S., & Sivakumar, V. (2024) · The Journal of Clinical and Scientific Research · doi:10.4103/jcsr.jcsr_98_23 · Cited by 1
Wang, C., Nieschlag, E., Swerdloff, R. S., Behre, H. M., Hellstrom, W. J. G., Gooren, L. J., Morales, Á., Kaufmann, J. M., Legros, J.-J., Lunenfeld, B., et al. (2010) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) · Cited by 1
[Testosterone and coronary artery disease].
Leibar-Tamayo, A., Odriozola, A. A., García‐Cruz, E., Fort, A. C., & Otero, J. (2013) · PubMed · Cited by 1
Erectile Dysfunction and Infertility
Soni, V., Pastuszak, A. W., & Khera, M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0425-9_6 · Cited by 1
Risk of hypogonadism in male survivors of childhood cancer
Ahern, T., & Hayes, F. J. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.277 · Cited by 1
Klinik und Diagnose von Hypogonadismus und Andropause
Bucher, J., & Christ, E. (2014) · Therapeutische Umschau · doi:10.1024/0040-5930/a000505 · Cited by 1
A Case of Hypogonadism Presented with Alopecia Universalis
Celbek, G., Turan, H., Aydın, Y., & Ermış, F. (2013) · Balkan Medical Journal · doi:10.5152/balkanmedj.2013.8216 · Cited by 1
Treatment of Hypogonadism in Men
Mehta, A., Paduch, D. A., & Goldstein, M. (2012) · Springer eBooks · doi:10.1007/978-1-4471-4405-2_5 · Cited by 1
Hipogonadismo de inicio tardío: revisión de conceptos y pautas diagnósticas
García-Herrera, D. A., Vázquez-Niño, C. L., Rosales, R. G., Castro, M. A. A., & Ruvalcaba-Oceguera, G. E. (2015) · Revista Mexicana de Urología · doi:10.1016/j.uromx.2015.11.001 · Cited by 1
Testicular Changes in Elderly Men
Nistal, M., González‐Peramato, P., & Serrano, Á. (2017) · Springer eBooks · doi:10.1007/978-3-319-49364-0_39 · Cited by 1
Testosterone replacement therapy and the knowledge gap
Yi, Y., & Dupree, J. M. (2017) · Nature Reviews Urology · doi:10.1038/nrurol.2017.63 · Cited by 1
Hypogonadism in Male Sexual Dysfunction
Stoian, D. L., Mozos, I. M., Craina, M. L., Paul, C., Velea, I. P., Schiller, A., & Crăciunescu, M. (2017) · InTech eBooks · doi:10.5772/intechopen.69107 · Cited by 1
Testosterone Deficiency and Other Testicular Disorders in Kidney Disease
Goldman, A. L., & Bhasin, S. (2019) · Springer eBooks · doi:10.1007/978-3-319-97765-2_9 · Cited by 1
Wang, K., Chen, X., Cheng, T. D., Qiu, P., Bird, V. Y., & Prosperi, M. (2019) · Hormones and Cancer · doi:10.1007/s12672-019-00369-y · Cited by 1
Graybill, S. D., & Vigersky, R. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-4975-1.00053-x · Cited by 1
Taussky, D., Delouya, G., Lambert, C., Bahary, J.-P., & Fred Saad, C. (2020) · Andrologia · doi:10.1111/and.13731 · Cited by 1
Meftah, N., Bijani, A., Hosseini, S. R., & Soleimani, A. M. (2021) · PubMed Central · doi:10.22088/cjim.12.2.135 · Cited by 1
Sex Hormone Disturbances in Athletes: Implications for Voice
Hamdan, A., Sataloff, R. T., & Hawkshaw, M. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-69831-7_10 · Cited by 1
Study of vitamin D status in male patients with hypogonadism
Albassiouny, A., El-Aghoury, A. A., Zahran, A., Bondok, M. E., & Elwafa, R. A. (2020) · Egyptian Journal of Obesity Diabetes and Endocrinology · doi:10.4103/ejode.ejode_4_19 · Cited by 1
Anabolic and anticatabolic agents in kidney disease and kidney failure
Chiang, J. M., & Johansen, K. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818540-7.00040-9 · Cited by 1
Epidemiology and Diagnosis of Hypogonadism
Fode, M. M., Quallich, S. A., Reisman, Y., Sønksen, J., & Ohl, D. A. (2012) · Springer eBooks · doi:10.1007/978-1-4471-4405-2_3 · Cited by 1
Errors in Abstract, Text, and Table in: Burden of Dizziness and Vertigo in the Community
(2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.573 · Cited by 1
Clinical Manifestation and Diagnosis of Androgen Deficiency
Święcicka, A., & Wu, F. C. W. (2017) · Endocrinology · doi:10.1007/978-3-319-44441-3_23 · Cited by 1
Meston, C. M., Freihart, B. K., & Stanton, A. M. (2023) · Oxford University Press eBooks · doi:10.1093/med-psych/9780197542521.003.0017 · Cited by 1
Park, J.-Y., Seok, J., Cho, K.-S., Kang, D., Kim, J., Do, S.-H., Na, H., Jang, S., & Ahn, R. S. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2356667 · Cited by 1
Estudo da disfunção erétil em uma população jovem de homens brasileiros
Martins, F. G. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2008.tde-19112008-164741 · Cited by 1
Advani, A. (2011) · Journal of Pharmacy Practice · doi:10.1177/0897190010397713 · Cited by 1
Commentary on "The association between sexual function and prostate cancer risk in US veterans"
Wang, K., & Cottler, L. B. (2016) · Asian Journal of Andrology · doi:10.4103/1008-682x.196853 · Cited by 1
Metadata
- Authors
- Araujo, A. B., Esche, G. R., Kupelian, V., O’Donnell, A. B., Travison, T. G., Williams, R. E., Clark, R. V., & McKinlay, J. B.
- Affiliations
- New England Research Institutes, Inc. (A.B.A., G.R.E., V.K., A.B.O., T.G.T., J.B.M.), Watertown, Massachusetts 02472
- New England Research Institutes (US)
- GlaxoSmithKline (United States) (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2007-11-01
- Volume
- 92
- Issue
- 11
- Pages
- 4241-4247
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2135798327
- Cited by
- 720
- References
- 45
- Citations by year
- 2026: 16 · 2025: 32 · 2024: 23 · 2023: 31 · 2022: 46 · 2021: 30 · 2020: 40 · 2019: 29 · 2018: 28 · 2017: 46 · 2016: 58 · 2015: 49 · 2014: 57 · 2013: 48 · 2012: 45
- FWCI
- 25.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (R01AG020727)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK56842)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Keywords
- androgen deficiency, free testosterone, prevalence, men, low libido, erectile dysfunction, osteoporosis, sex hormone-binding globulin, age-related decline, racial and ethnic differences, sex steroid levels, sleep disorders, depressive mood, physical performance, men's health, older men
- MeSH terms
- Adult, Aged, Androgens, Boston, Data Interpretation, Statistical, Endocrine System Diseases, Ethnicity, Humans, Male, Middle Aged, Gonadal Steroid Hormones, Testosterone, Cluster Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
